Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

Purpose We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based chemoradiation in locally advanced rectal cancer. Methods Between April 2004 and December 2007, 25 patients with clinically staged T3N1 ( n = 20) or T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2010-03, Vol.76 (3), p.824-830
Hauptverfasser: Crane, Christopher H., M.D, Eng, Cathy, M.D, Feig, Barry W., M.D, Das, Prajnan, M.D, Skibber, John M., M.D, Chang, George J., M.D, Wolff, Robert A., M.D, Krishnan, Sunil, M.D, Hamilton, Stanley, M.D, Janjan, Nora A., M.D, Maru, Dipen M., M.D, Ellis, Lee M., M.D, Rodriguez-Bigas, Miguel A., M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!